The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MedAssessment
Leadership - MedAssessment
Stock and Other Ownership Interests - MedAssessment
Consulting or Advisory Role - OncXerna Therapeutics; Roivant; VM Pharma; Xencor
First-time in-human study of VMD-928, an oral allosteric TrkA selective inhibitor targeting TrkA protein overexpression, in patients with solid tumors or lymphoma.
 
Vincent Chung
Consulting or Advisory Role - Apeiron Biologics; Gritstone Bio; Ipsen; Westwood Bioscience
Speakers' Bureau - Celgene; Ipsen
Research Funding - Merck (Inst); Roche (Inst)
 
Ling Wang
Employment - VM Pharma; VM Pharma
Leadership - VM Pharma; VM Pharma
Stock and Other Ownership Interests - VM Pharma; VM Pharma
Patents, Royalties, Other Intellectual Property - VM Pharma; VM Pharma
 
Margaret S. Fletcher
No Relationships to Disclose
 
Erminia Massarelli
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - Genentech/Roche; Merck
Speakers' Bureau - AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
 
Mihaela C. Cristea
Honoraria - Abbvie; AstraZeneca
Consulting or Advisory Role - Abbvie; AstraZeneca
Speakers' Bureau - AstraZeneca
 
Sailaja Kamaraju
Honoraria - Athenex; University of Wisconsin
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Agendia; Pfizer
 
Angela Tatiana Alistar
Consulting or Advisory Role - Rafael Pharmaceuticals
Speakers' Bureau - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Rafael Pharmaceuticals
 
Chao Feng
Employment - VM Pharma; VM Pharma
Patents, Royalties, Other Intellectual Property - VM Pharma
 
You Li
Employment - VM Pharma; VM Pharma
Patents, Royalties, Other Intellectual Property - VM Pharma
 
Roger Lewis Whiting
Employment - VM Pharma
Leadership - VM Pharma
Stock and Other Ownership Interests - VM Pharma
Consulting or Advisory Role - VM Pharma
 
Giuseppe Giaccone
Consulting or Advisory Role - CStone Pharmaceuticals; Daiichi
Research Funding - Bayer; Incyte; MedImmune (Inst)
 
David S. Hong
Stock and Other Ownership Interests - MolecularMatch; OncoResponse; Presagia
Consulting or Advisory Role - Acuta; Adaptimmune; Alphasights; Amgen; Axiom Biotechnologies; Baxter; Bayer; Boxer Capital; COG; EcoR1 Capital; Genentech; Gerson Lehrman Group; GroupH; GroupH; Guidepoint Global; H.C. Wainwright & Co.; HCW Precision; Infinity Pharmaceuticals; Infinity Pharmaceuticals; Janssen; Medscape; Merrimack; Numab; Pfizer; Prime Oncology; Seagen; ST Cube; Takeda; Tavistock Life Sciences; Trieza Therapeutics; WebMD; WebMD
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Aldai Norte (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Erasca, Inc (Inst); Fate Therapeutics (Inst); Genentech (Inst); Genmab (Inst); Ignyta (Inst); Infinity Pharmaceuticals (Inst); Kite, a Gilead company (Inst); Kyowa (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); miRNA Therapeutics (Inst); Molecular Templates (Inst); Mologen (Inst); National Cancer Institute (Inst); Navire (Inst); Novartis (Inst); Numab (Inst); Pfizer (Inst); Seagen (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Verastem (Inst); VM Pharma (Inst)
Travel, Accommodations, Expenses - AACR; ASCO; Bayer Schering Pharma; Genmab; Loxo; miRNA Therapeutics; Society for Immunotherapy of Cancer
 
Jay Wu
Employment - VM Pharma; VM Pharma; VM Pharma; VM Pharma
Leadership - VM Pharma; VM Pharma; VM Pharma; VM Pharma
Stock and Other Ownership Interests - VM Pharma; VM Pharma; VM Pharma; VM Pharma
Patents, Royalties, Other Intellectual Property - VM Pharma; VM Pharma; VM Pharma; VM Pharma